Structural basis for human Ca<sub>v</sub>1.2 inhibition by multiple drugs and the neurotoxin calciseptine.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37972591.
- Also identified by DOI 10.1016/j.cell.2023.10.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ca<sub>v</sub>1.2 channels play crucial roles in various neuronal and physiological processes. Here, we present cryo-EM structures of human Ca<sub>v</sub>1.2, both in its apo form and in complex with several drugs, as well as the peptide neurotoxin calciseptine. Most structures, apo or bound to calciseptine, amlodipine, or a combination of amiodarone and sofosbuvir, exhibit a consistent inactivated conformation with a sealed gate, three up voltage-sensing domains (VSDs), and a down VSD<sub>II</sub>. Calciseptine sits on the shoulder of the pore domain, away from the permeation path. In contrast, when pinaverium bromide, an antispasmodic drug, is inserted into a cavity reminiscent of the IFM-binding site in Na<sub>v</sub> channels, a series of structural changes occur, including upward movement of VSD<sub>II</sub> coupled with dilation of the selectivity filter and its surrounding segments in repeat III. Meanwhile, S4-5<sub>III</sub> merges with S5<sub>III</sub> to become a single helix, resulting in a widened but still non-conductive intracellular gate.
Medical subject headings
- Calcium Channels, L-Type
- Elapid Venoms